Potent Anti-R5 Human Immunodeficiency Virus Type 1 Effects of a CCR5 Antagonist, AK602/ONO4128/GW873140, in a Novel Human Peripheral Blood Mononuclear Cell Nonobese Diabetic-SCID, Interleukin-2 Receptor g-Chain-Knocked-Out AIDS Mouse Model
Nakata, H.; Maeda, K.; Miyakawa, T.
Journal of Virology 79(4): 87-96
2005
ISSN/ISBN: 0022-538X Accession: 018062472
Full Text Article emailed within 1 workday
Payments are secure & encrypted
Related References
Nakata, H.; Maeda, K.; Miyakawa, T.; Shibayama, S.; Matsuo, M.; Takaoka, Y.; Ito, M.; Koyanagi, Y.; Mitsuya, H. 2005: Potent anti-R5 human immunodeficiency virus type 1 effects of a CCR5 antagonist, AK602/ONO4128/GW873140, in a novel human peripheral blood mononuclear cell nonobese diabetic-SCID, interleukin-2 receptor gamma-chain-knocked-out AIDS mouse model Journal of Virology 79(4): 2087-2096Hattori, S.; Ide, K.; Nakata, H.; Harada, H.; Suzu, S.; Ashida, N.; Kohgo, S.; Hayakawa, H.; Mitsuya, H.; Okada, S. 2009: Potent activity of a nucleoside reverse transcriptase inhibitor, 4'-ethynyl-2-fluoro-2'-deoxyadenosine, against human immunodeficiency virus type 1 infection in a model using human peripheral blood mononuclear cell-transplanted NOD/SCID Janus kinase 3 knockout mice Antimicrobial Agents and ChemoTherapy 53(9): 3887-3893
Hesselton, R.M.; Greiner, D.L.; Mordes, J.P.; Rajan, T.V.; Sullivan, J.L.; Shultz, L.D. 1995: High levels of human peripheral blood mononuclear cell engraftment and enhanced susceptibility to human immunodeficiency virus type 1 infection in NOD/LtSz-scid/scid mice Journal of Infectious Diseases 172(4): 974-982
van der Loo, J.C.; Hanenberg, H.; Cooper, R.J.; Luo, F.Y.; Lazaridis, E.N.; Williams, D.A. 1998: Nonobese diabetic/severe combined immunodeficiency (NOD/SCID) mouse as a model system to study the engraftment and mobilization of human peripheral blood stem cells Blood 92(7): 2556-2570
Horiuchi, S.; Koyanagi, Y.; Tanaka, Y.; Waki, M.; Matsumoto, A.; Zhou, Y.W.; Yamamoto, M.; Yamamoto, N. 1997: Altered interleukin-2 receptor alpha-chain is expressed in human T-cell leukaemia virus type-I-infected T-cell lines and human peripheral blood mononuclear cells of adult T-cell leukaemia patients through an alternative splicing mechanism Immunology 91(1): 28-34
Buitendijk, M.; Eszterhas, S.K.; Howell, A.L. 2014: Toll-like receptor agonists are potent inhibitors of human immunodeficiency virus-type 1 replication in peripheral blood mononuclear cells Aids Research and Human Retroviruses 30(5): 457-467
Hesselton, R.M.; Greiner, D.L.; Mordes, J.P.; Rajan, T.V.; Sullivan, J.L.; Schultz, L.D. 1995: High levels of human peripheral blood mononuclear cell engraftment and enhanced susceptibility to human immunodefiency virus type 1 infection in NOD/LtSz-scid/scid mice The Journal of Infectious Diseases 172(4): 974-982
Montoya, J.G.; Wood, R.; Katzenstein, D.; Holodny, M.; Merigan, T.C. 1993: Peripheral blood mononuclear cell human immunodeficiency virus type 1 proviral DNA quantification by polymerase chain reaction: relationship to immunodeficiency and drug effect Journal of Clinical Microbiology 31(10): 2692-2696
Kusuhara, H.; Matsuyuki, H.; Okumoto, T. 1997: Effects of nonsteroidal anti-inflammatory drugs on interleukin-1 receptor antagonist production in cultured human peripheral blood mononuclear cells Prostaglandins 54(5): 795-804
Kusuhara, H.; Matsuyuki, H.; Okumoto, T. 1997: Effects of nonsteroidal anti-inflammatory drugs on interleukin-1 receptor antagonist production in cultured human peripheral blood mononuclear cells Prostaglandins 54(5): 795-804,.
Zhang, L.J.; Waters, C.A.; Poisson, L.R.; Estis, L.F.; Crumpacker, C.S. 1997: The interleukin-2 fusion protein, DAB389IL-2, inhibits the development of infectious virus in human immunodeficiency virus type 1-infected human peripheral blood mononuclear cells Journal of Infectious Diseases 175(4): 790-794
Zanussi, S.; D'Andrea, M.; Simonelli, C.; Trabattoni, D.; Bortolin, M.T.; Caggiari, L.; Tirelli, U.; Clerici, M.; De Paoli, P. 1999: The effects of CD40 ligation on peripheral blood mononuclear cell interleukin-12 and interleukin-15 production and on monocyte cd14 surface antigen expression in human immunodeficiency virus-positive patients Scandinavian Journal of Immunology 49(3): 286-292
de Haard, J.J.; Kazemier, B.; Oudshoorn, P.; Boender, P.; van Gemen, B.; Koolen, M.J.; van der Groen, G.; Hoogenboom, H.R.; Arends, J.W. 1998: Selection of human anti-human immunodeficiency virus type 1 envelope single-chain antibodies from a peripheral blood cell-based phage repertoire Journal of General Virology 79: 2883-2894
Akridge, R.E.; Reed, S.G. 1996: Interleukin-12 decreases human immunodeficiency virus type 1 replication in human macrophage cultures reconstituted with autologous peripheral blood mononuclear cells Journal of Infectious Diseases 173(3): 559-564
Mhashilkar, A.M.; LaVecchio, J.; Eberhardt, B.; Porter-Brooks, J.; Boisot, S.; Dove, J.H.; Pumphrey, C.; Li, X.; Weissmahr, R.N.; Ring, D.B.; Ramstedt, U.; Marasco, W.A. 1999: Inhibition of human immunodeficiency virus type 1 replication in vitro in acutely and persistently infected human CD4+ mononuclear cells expressing murine and humanized anti-human immunodeficiency virus type 1 Tat single-chain variable fragment intrabodies Human Gene Therapy 10(9): 1453-1467
King, M.A.; Covassin, L.; Brehm, M.A.; Racki, W.; Pearson, T.; Leif, J.; Laning, J.; Fodor, W.; Foreman, O.; Burzenski, L.; Chase, T.H.; Gott, B.; Rossini, A.A.; Bortell, R.; Shultz, L.D.; Greiner, D.L. 2009: Human peripheral blood leucocyte non-obese diabetic-severe combined immunodeficiency interleukin-2 receptor gamma chain gene mouse model of xenogeneic graft-versus-host-like disease and the role of host major histocompatibility complex Clinical and Experimental Immunology 157(1): 104-118
Lucey, D.R.; Pinto, L.A.; Bethke, F.R.; Rusnak, J.; Melcher, G.P.; Hashemi, F.N.; Landay, A.L.; Kessler, H.A.; Paxton, R.J.; Grabstein, K.; Shearer, G.M. 1997: In vitro immunologic and virologic effects of interleukin 15 on peripheral blood mononuclear cells from normal donors and human immunodeficiency virus type 1-infected patients Clinical and Diagnostic Laboratory Immunology 4(1): 43-48
Douglas, J.L.; Lin, W.Y.; Panis, M.L.; Veres, G. 2001: Efficient human immunodeficiency virus-based vector transduction of unstimulated human mobilized peripheral blood CD34+ cells in the SCID-hu Thy/Liv model of human T cell lymphopoiesis Human Gene Therapy 12(4): 401-413
Conti, P.; Feliciani, C.; Barbacane, R.C.; Panara, M.R.; Reale, M.; Placido, F.C.; Sauder, D.N.; Dempsey, R.A.; Amerio, P. 1992: Inhibition of interleukin-1β mRNA expression and interleukin-1α and β secretion by a specific human recombinant interleukin-1 receptor antagonist in human peripheral blood mononuclear cells Immunology (Oxford) 77(2): 245-250
Choi, H.J.; Dinarello, C.A.; Shapiro, L. 2001: Interleukin-18 inhibits human immunodeficiency virus type 1 production in peripheral blood mononuclear cells Journal of Infectious Diseases 184(5): 560-568